Get Dettol Kit worth Rs. 130 for just Rs. 4
Common Specialities
Common Issues
Common Treatments

Luprotas 22.5Mg Vial

Manufacturer: Intas Pharmaceuticals Ltd
Medicine composition: Leuprorelin
Prescription vs.OTC: Prescription by Doctor required

Luprotas 22.5Mg Vial, also known as leuprolide, is a manufactured version of a hormone called gonadotropin-releasing hormone. It is primarily used to treat hormone-based tumors like in advanced prostate cancer, breast cancer, lymphoma, certain kinds of leukaemia, uterine fibroids, and endometriosis. Apart from these, it is also used to treat early onset of puberty. It is administered through injection into a muscle or under the skin. Prolonged usage leads to substantial decline of testosterone in male and decrease in estradiol in females.

In some cases, Luprotas 22.5Mg Vial may be harmful if inhaled, can cause allergic skin reactions, asthma-like symptoms and breathing difficulties. Pregnant women should avoid using this drug as it can harm the unborn child. Other common side effects of Luprotas 22.5Mg Vial include hot flashes, mood swings, difficulty in sleeping, headaches, pain at the site of injection, night sweats, stomach upset, diarrhoea, constipation, stomach pain, acne, swollen breasts or tender breasts, high blood sugar and problems with the pituitary gland. It is also used to avoid premature ovulation in in-vitro fertilisation processes. This drug is also used to delay puberty in transgender boys and girls until they are old enough to start hormone-replacement therapy. It has also been use on an experimental basis to reduce sexual urges in paedophiles and other kinds of paraphilias.

Information given here is based on the salt and content of the medicine. Effect and uses of medicine may vary from person to person. It is advicable to consult a Oncologist before using this medicine.

and precocious puberty (premature puberty).
In addition to its intended effect, Luprotas 22.5Mg Vial may cause some unwanted effects too. In such cases, you must seek medical attention immediately. This is not an exhaustive list of side effects. Please inform your doctor if you experience any adverse reaction to the medication.
Decreased libido
Testicular atrophy
Increased sweating
Bone pain
Hot flashes
Injection site reaction.
Is It safe with alcohol?
Interaction with alcohol is unknown. Please consult your doctor.
Are there any pregnancy warnings?
Lupride depot 22.50mg injection is highly unsafe to use during pregnancy.
Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor.
Are there any breast-feeding warnings?
Unknown. Human and animal studies are not available. Please consult your doctor.
Is it safe to drive while on this medicine?
Does this affect kidney function?
There is no data available. Please consult doctor before consuming the drug.
Does this affect liver function?
There is no data available. Please consult doctor before consuming the drug.
Are there any missed dose instructions?
If you miss a dose of Leuprorelin, please consult your doctor.
Luprotas 22.5Mg Vial is a class of gonadotropin hormone receptor agonist which is used for treating prostate cancer, breast cancer, endometriosis, uterine fibroids and early puberty. It is generally administered through an injection that results in lowering secretion of follicle stimulating and luteinizing hormones thereby decreasing the level of testosterone and estrogen in the blood.
Disclaimer: The information produced here is best of our knowledge and experience and we have tried our best to make it as accurate and up-to-date as possible, but we would like to request that it should not be treated as a substitute for professional advice, diagnosis or treatment.

Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.

Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.

Popular Questions & Answers

Hi, I am taking daily 38 units of Insugen 50/50 100 iu in Morning time and 30 units in Night time. Can I take same dosage 38 units and 30 units with Insugen 50/50 40iu with 100 units syringe?

MBBS, CCEBDM, Diploma in Diabetology, Diploma in Clinical Nutrition & Dietetics, Cetificate Course In Thyroid Disorders Management (CCMTD)
Endocrinologist, Dharwad
Hi, I am taking daily 38 units of Insugen 50/50 100 iu in Morning time and 30 units in Night time. Can I take same do...
Mr. lybrate-user, Thanks for the query. You can take insulin mentioned with a 40 units syringe, but you will have to change the quantity proportionately. 100 iu /ml has more insulin in one ml compared to 40 iu / ml vial. So the quantity has to be increased by 2.5 times. To get amount of insulin. To avoid this confusion, it is better to stick to 100 iu/ml Insulin. Thanks.
1 person found this helpful

Dr. Sir, I am diabetic patient and taking insulin injection. I am in Dubai, UAE and when I go to Andhra on vacation it takes around 12 hours to reach my native place. If I take Insulin injections without keeping in ice for 12 hours, will it spoil and becomes useless? Please reply. (Ahmed Ali)

Practical Course In Diabetology, Post Graduate Course In Diabetology, MBBS
Endocrinologist, Jammu
Dr. Sir, I am diabetic patient and taking insulin injection. I am in Dubai, UAE and when I go to Andhra on vacation i...
No it won't become useless. In fact vial or cartridge in use should be at room temperature.Nothing will happen upto one month.
1 person found this helpful

Respective doctor hello, actually I got my first vrdl on this year February 2017 with titter 1: 16 after that doctor gave me two shots of penidure LA 12 in each buttock (1 vial each) after that on October 29 2017 I again tested and got my titter 1: 8. But after that I went for direct vrdl test without titter and it was negative. I am confused. Sir I want to get married but I do not to take risk. I do not know whether I will be cure or not. Very depressed N.B. Hepatitis B and C = Negative ICTC = Negative.

MBBS, MD - Psychiatry
Psychiatrist, Delhi
Respective doctor hello, actually I got my first vrdl on this year February 2017 with titter 1: 16 after that doctor ...
Syphilis is usually easily treated with antibiotics. I presume that treating doctor would have already explained the expected outcome to you. However, if you continue to experience anxiety and just think of negative outcomes, you should consult a Psychiatrist for diagnosis and treatment. It is most likely anxiety Disorder, which is easily treated.

Sir I am 21 years old and I want hepatitis b vaccination sir what is price of vaccine.

MD - Homeopathy
Homeopath, Aurangabad
Sir I am 21 years old and I want hepatitis b vaccination sir what is price of vaccine.
SERUM Institute of India Ltd (SIIL) has slashed prices of its Hepatitis B vaccine, Gene Vac-B by about 40 per cent. The maximum retail price of 10 ml vial is now Rs 875 as againt Rs 1,400 earlier. The 0.5 ml (single dose) for paediatric use will now cost Rs 55 as against Rs 90.
1 person found this helpful

I am always getting cold, running nose cough & saliva. Nearly more than 30 days it's getting often .& throat infection. This is first time. The cold stop & start once again. Please suggest me what will problem & what to be do.

Bachelor of Ayurveda, Medicine and Surgery (BAMS)
I am always getting cold, running nose cough & saliva. Nearly more than 30 days it's getting often .& throat infectio...
Common cold is vial infection cap nilsin 1 thrice a day x 5-6 days steam inhalation, gargle with salt warm water eat light food warm and fresh hold milk no AC slow fan.

Popular Health Tips

What is Platelet Rich Plasma Therapy - PRP?

Dermatologist, Delhi
What is Platelet Rich Plasma Therapy - PRP?

Platelet-rich plasma (PRP) treatment includes infusion of the patient's own particular platelets and fibrin for the corrective treatment of wrinkles or scars in the face, hands, and neck. Referred to some as the "vampire facelift", it is less intrusive than plastic surgery, takes around 20 minutes for every treatment, and offers enhancements for up to year and a half.

Definition of PRP Therapy technique for enhancing facial appearance

PRP is safe and fast readiness of platelet-rich fibrin lattice, which is a sort of regenerative solution that utilizations platelets to restore the skin.

PRP Treatment is utilized cosmetically to treat volume misfortune in the face, hands, and neck - especially the crepey skin under the eyes and neck - and in addition wrinkles, acne scarring, and stretch marks.

Through what components do infusions of PRP reestablish facial appearance?

Platelets assume a part in ceasing draining and in repairing harmed veins and cells in the body. Platelets additionally contain substances called "development calculates" that initiate and revive cells in our body. Not at all like fillers that utilization different engineered substances, patient's common science to address skin deformities and volume misfortune, activating creation of new cells and collagen arrangement.

To what extent does the system take, and how it is performed?

PRP is a snappy 20-minute strategy. After 9 cm3 of blood (roughly 1 vial) is drawn from the patient, it is spun down in an axis for 6 minutes at a pre-calculated speed to recover the most reasonable fibrin and platelets. After centrifugation, the platelet and fibrin segment of the blood (the top layer) is separated and re-injected into the range of concern region.

What kind of results can by and large be normal?

The outcomes are unobtrusive, with slow change in the infused range over a 3-to 5-week time span. Full rectification happens at 4-7 weeks and can keep going the length of year and a half.

What are the Risks or Intricacies?

Since, this filler is produced using the patient's own particular blood, there is no hazard for dismissal, disease, or an unfavorably susceptible response.

For what sorts of patients is this strategy most and minimum reasonable?

Any patient who wishes to diminish volume misfortune, almost negligible differences, and textural changes of the skin is reasonable for this system. It additionally offers to the patient who is searching for a characteristic way to deal with volumizing the face and treating or diminishing scarcely discernible differences.

To what extent changes are kept up? In the event that important, can the technique be rehashed, and assuming this is the case, with what foreseen result?

PRP can be rehashed, and better outcomes are seen with an aggregate of 2-3 medicines given 3-4 months separated. Patients can hope to see better outcomes as they get more medicines. With time, the aftereffects of PRP show signs of improvement and better.

How does PRP treatment contrast and infusions of filler, Botox, or surgical facelifts?

This methodology can be consolidated with dermal fillers, Botox infusions, and laser surgery, and in addition facial surgery. PRP fabricates tissue after some time, though customary filler separates after some time.

In what circumstances may PRP treatment in addition to filler infusions be useful?

It is pleasant to layer PRP with conventional fillers. On the off chance that a patient has volume misfortune with a considerable measure of scarcely discernible differences and textural transforms, it is useful to make another establishment of collagen and utilize dermal fillers for the almost negligible differences.

What is your general assessment of the part that PRP treatment ought to play in facial restoration?

PRP treatment is extremely encouraging in facial restoration. Results are ideal when patients get a mix of PRP, dermal fillers, and laser treatment.


1 person found this helpful

Mantoux Test or Tuberculin Skin Test

MD - Pathology
Pathologist, Noida
Mantoux Test or Tuberculin Skin Test

Diagnosis of tuberculosis is based on a combination of clinical features, smear examination of sputum where available, tuberculin skin testing or Mantoux test, chest X-ray and Histopathologic / cytologic examination as appropriate. Common clinical features are weight loss, persistent fever and /or cough of more than 2 weeks duration and history of close contact with another Tuberculosis patient.

Mantoux test also known as Tuberculin skin test is used for the detection of infection by Mycobacterium Tuberculosis bacteria. The test consists of slowly injecting a liquid intradermally (superficially within the layers of the skin) on the forearm, leading to formation of a raised vesicle which should be easily visible to the naked eye. This liquid, used in India, is Tuberculin PPD RT 23 strain. Tuberculin is a glycerol extract of the Tuberculosis bacteria. This is one of the two WHO accepted standard tuberculins, apart from PPD-S. In India, where the prevalence of tuberculosis is high, the recommended dose of this liquid is 0.1 ml of 1 TU (TU stands for tuberculin units) .1 TU is the strength of the liquid mentioned on the vial. This liquid is usually administered by a very tiny syringe, usually of 26 gauge. (Needle diameter).

Please click on the link to watch a video  demonstrating  how this procedure is performed.

Test principle : The individual who has been infected with Tubercle bacilli responds with a hypersensitivity reaction at the test site in the form of induration. Induration is the palpable raised hardening of the skin, while erythema refers to redness of skin. Only induration is clinically significant and measured after 48 to 72hours following injection. Diameter of the Induration is measured by a scale in millimetres perpendicular to the long axis of the forearm.

Interpretation of the tuberculin test

  1. Size of induration 15 mm and above : - signifies infection with tubercle bacilli
  2. Size of induration 10-14 mm : - could be due to infection with tubercle bacilli, BCG induced sensitivity, or due to cross reaction with other environmental mycobacteria.

It is more likely to be attributable to infection with tubercle bacilli in case of history of contact with smear positive case of pulmonary TB, clinically confirmed TB OR X-ray consistent with active TB.

  1. Size of induration 5 -9 mm: usually non tuberculous in nature generally
  2. Size of induration <5 mm : indicates absence of any type of mycobacterial infection.

Precautions during this procedure :

  1. If a raised vesicle does not appear it means that the liquid has been injected too deeply, and the test should be repeated on the other arm. If the same arm is used the injection site should be should be separated at least 5 cm from the first injection site.
  2. Occasional patients may experience severe allergic reaction to the tuberculin PPD

Comments :

  1. Larger the size of the induration, higher the probability of presence of infection with tubercle bacilli.
  2. Almost all reactions with induration more than 15 mm maybe considered attributable to infection with tubercle bacilli.
  3. Formation of necrosis (ulcer) at the test site, indicates high degree of tuberculin sensitivity and suggests presence of infection with tubercle bacteria.
  4. Tuberculin reaction may be suppressed (falsely low) in presence of immunosuppressive states. Like HIV, malnutrition, patient on steroid therapy etc.
  5. Mantoux test is generally not recommended for infants less than 12 weeks old. If the test turns out to be positive, then it is significant, but if the test is negative, then the test needs to be repeated again.
  6. The tuberculin test detects only the presence or absence of tuberculosis infection. The presence of infection is not synonymous with disease. It simply means, that even if you have tuberculosis infection in your body, as detected by positive Mantoux test, it does not mean you have active Tuberculosis in your body and require anti tuberculosis drugs in all cases. The clinician will correlate your mantoux test result with other tests ( as mentioned at the top of the blog) to give you a final picture.  
  7. For more such interesting articles please visit my blogsite
5 people found this helpful

Select Proper Insulin Syringe

Fellowship of College of General Practice (FCGP), MD - General Medicine, MBBS
General Physician, Nagapattinam
Select Proper Insulin Syringe

There are 2 types of syringes for insulin injection. 1 is made for 40 units per ml. Which is commonly prescribed by doctors. Which is suitable for 40units insulin per ml vial. 2 is 100 units per ml syringe suitable for 100 units insulin per ml vial. Use appropriate insulin syringe.

4 people found this helpful

Testosterone Levels in Men - Ways to Measure it!

BAMS, MD Ayurveda
Sexologist, Navi Mumbai
Testosterone Levels in Men - Ways to Measure it!

The body and its functions depend to a great extent on the play of hormones, which can greatly affect how we function and the quality of life that we enjoy. Men and women have many different kinds of hormones. Testosterone is a male hormone that is found mainly in the testicles of males, and is responsible for the development of their sexual behaviour and other typical male characteristics. 

Why Measure Testosterone?

This hormone affects the physical, mental and emotional side of men to a great extent and an alteration can also cause health problems. For example, symptoms like sudden weight gain and mood swings are just a few that can point towards a low T score, which is a measure of testosterone. This is why it is important to measure the levels of this hormone. 

There are many ways to measure testosterone levels in men, which are as follows. 

  1. Sweat: One of the foremost ways to measure testosterone levels is to get acquainted with the sweat and its smell, which is basically a function of the apocrine glands. The more you sweat, the more testosterone you have in your body. 
  2. Testicles: The size of the testicles also determines how much testosterone your body is producing. The smaller the size, the lower the level; while larger and firmer testicles will mean that your body is producing high levels of testosterone.
  3. Erections: The erection that a male enjoys is driven basically by the level of testosterone being produced in the body. The size and frequency of the erection basically speaks volumes of the T score. Infrequent and small erections can point at low levels of testosterone, low levels of nitric oxide, as well as malfunctioning dopamine receptors. 
  4. Saliva and blood spot test: This home-based test kit or a blood test at the doctor's clinic, can measure the level of testosterone that is being produced in the body, with the help of a vial that can ask for either saliva or blood In this method, you need to remember that the T score depends on the time of the day and is usually highest in the morning. Also, a blood test conducted by a doctor will have more accurate results. If you wish to discuss about any specific problem, you can consult a doctor.
6254 people found this helpful

First Vaccine Again Dengue

General Physician, Bangalore
First Vaccine Again Dengue

Dengvaxia - First vaccine against dengue:

Dengvaxia is a vaccine used to help protect adult or children against dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. Dengvaxia is given to adults, adolescents and children 9 through 45 years of age living in endemic areas.


Read more:-

Dengue symptoms and what to do if you think you have denguedengue fever - remedies using papaya leaf juice


Full prescribing info - dengvaxia


Dengue tetravalent vaccine (live, attenuated).

Indications / uses

Dengvaxia is a vaccine used to help protect adult or children against dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. Dengvaxia is given to adults, adolescents and children 9 through 45 years of age living in endemic areas.

Dosage / direction for use

The patient will receive 3 injections of 0.5 ml each at 6-month intervals.

The first injection will occur at the chosen or scheduled date; the second injection, 6 months after the first injection; and the third injection, 6 months after the second injection. Dengvaxia should be used according to the local vaccination schedule.

If the patient forgot an injection of dengvaxia: if the patient missed a scheduled injection, the physician will decide when to give the missed injection.

It is important that the patient follows the instructions of the physician, pharmacist or nurse regarding return visits for the follow-up injection. If the patient forgets or is not able to go back to the physician, pharmacist or nurse at the scheduled time, ask the physician, pharmacist or nurse for advice.

Administration: dengvaxia is given by the physician or nurse as an injection underneath the skin (subcutaneous route) in the upper arm.


Do not use dengvaxia if the patient is allergic (hypertensive) to the active substances or any of the other ingredients of dengvaxia listed in description (see description); has developed an allergic reaction after prior administration of dengvaxia. Signs of an allergic reaction may include an itchy rash, shortness of breath and swelling of the face and tongue; is suffering from a disease with mild to high fever or acute disease. In this case, the physician will postpone the administration of dengvaxia until the patient has recovered; has a weakened immune system, for example due to a genetic defect, hiv infection or therapies that affect the immune system (for example, high-dose corticosteroids or chemotherapy); is pregnant; is breastfeeding.

Use in pregnancy lactation: Dengvaxia must not be given to pregnant or breastfeeding women.

If the patient is of child-bearing stage, the patient should take the necessary precautions to avoid pregnancy for 1 month following administration of dengvaxia; is pregnant or breastfeeding, the patient thinks may be pregnant or is planning to have a baby, ask the physician, pharmacist or nurse for advice before receiving dengvaxia.

Special precautions

Inform the physician, pharmacist or nurse before receiving dengvaxia if the patient is taking an immunosuppressive treatment (prednisone or equivalent to 20 mg or 2 mg/kg for 2 weeks or more). The physician will postpone administration of dengvaxia until 4 weeks after the treatment is discontinued; has experienced any health problems after prior administration of any vaccines. The physician will carefully consider the risks and benefits of vaccination.

As with all vaccines, dengvaxia may not protect 100% of persons who have been vaccinated. Vaccination with dengvaxia is not a substitute for protection against mosquito bites. The patient should take appropriate precautions to prevent mosquito bites, including the use of repellents, adequate clothing, and mosquito nets.

Fainting, sometimes accompanied by falling, can occur (mostly in adolescents) following, or even before, any injection with a needle. Therefore inform the physician, pharmacist or nurse if the patient fainted with a prior injection.

Adults above 45 years of age: adults above 45 years of age should not receive the vaccine.

Driving and using machines: no data are available on the effects of dengvaxia on the ability to drive or use machines.

Use in children: Children less than 9 years of age should not receive the vaccine.


Side effects:

Like all medicines, dengvaxia can cause side effects, although not all patients get them.

Serious allergic reactions: If any of these symptoms occur after leaving the place where the patient received an injection, consult a physician immediately: difficulty in breathing, blueness of the tongue or lips, a rash, swelling of the face or throat, low blood pressure causing dizziness or collapse.

When these signs and symptoms occur they usually develop quickly after the injection is given and while the patient is still in clinic or physician's surgery.

Serious allergic reactions are very rare (may affect up to 1 in 10,000 people), after receiving any vaccine.

Other side effects: The following side effects were reported during clinical studies in children, adolescents and adults (from 9 to and including 60 years of age). Most of the reported side effects occurred within 3 days after the injection of the vaccine: very common (may affect more than 1 user in 10): headache, muscle pain (myalgia), generally feeling unwell (malaise), feeling of weakness (asthenia), injection site pain, fever.

Common (may affect up to 1 user in 10): Injection site reactions: redness (erythema), bruising (hematoma), swelling, and itching (pruritus).

Uncommon (may affect up to 1 user in 100): Infections of the upper respiratory tract, dizziness, sore throat (oropharyngeal pain), cough, runny nose (rhinorrhea), nausea, skin eruption (rash), neck pain, hardening of skin at the injection site (injection site induration).

Additional side effects in adults (from 18 to and including 60 years of age): Uncommon (may affect up to 1 user in 100): swollen glands (lymphadenopathy), migraine, joint pain (arthralgia), flu-like symptoms (influenza-like illness).

Additional side effects in children and adolescents (from 9 to and including 17 years of age: Uncommon (may affect up to 1 user in 100), Itchy rash (urticaria).

Reporting of side effects or any suspected adverse event: If the patient experiences any side effects after vaccination, advised to seek immediate medical attention.

By reporting side effects, it can help provide more information on the safety of the vaccine.



Using other medicines and dengvaxia: Dengvaxia may not have an optimal effect if it used at the same time as medicines that suppress the immune system such as corticosteroids or chemotherapy.

Inform the physician, pharmacist or nurse if the patient is taking or has recently taken any other vaccines or any other medicines, including medicines obtained without a prescription.


Caution for usage:

Before administering any biological, the person responsible for administration must take all precautions to prevent allergic or other reactions. As with all injectable vaccines, appropriate medical treatment and supervision must always be readily available in the event of an anaphylactic reaction following the administration of dengvaxia.

Epinephrine (1:1000) and other appropriate agents used to control immediate allergic reactions must be available to treat unexpected events such as anaphylaxis.

Dengvaxia must not be mixed with other medicinal products in the same syringe.

Dengvaxia must not be administered by intravascular injection under any circumstances.

Syncope (fainting) can occur following, or even before, any vaccination as a psychogenic response to injection with a needle. Procedures should be in place to prevent injury from falling and to manage syncopal reactions.

Separate syringes and needles, separate injection sites and preferably separate limbs must be used if any other vaccine (s) or medicinal product (s) is/are concomitantly administered.

Dengvaxia is reconstituted by transferring all the solvent (0.4% sodium chloride solution) provided in the blue-labeled pre-filled syringe into the vial of freeze dried powder with a yellowish green flip off cap. The pre-filled syringe is fitted with a sterile needle for this transfer. The vial is then gently swirled. After complete dissolution, a 0.5 ml dose of reconstituted suspension is withdrawn into the same syringe. For injection, the syringe should be fitted with the new sterile needle.

The suspension should be visually inspected prior to administration. After reconstitution, dengvaxia is clear, colorless liquid with the possible presence of white to translucent particles (of endogenous nature).

After reconstitution with the solvent provided, dengvaxia must be used immediately.

Any unused dengvaxia or waste material should be disposed of, preferably by heat inactivation or incineration, in accordance with local regulations.

Do not throw away any medicines via wastewater or household waste. Ask a pharmacist on how to throw away medicines that no longer use. These measures will help to protect the environment.



Store in a refrigerator (2°c-8°c). Do not freeze. Keep the vaccine in the outer carton in order to protect it from light.



After reconstitution, one dose (0.5 ml) contains 4.5-6.0 log10 ccid50* of each serotype of the cyd dengue virus** (1, 2, 3 and 4).

* ccid50: 50% cell culture infectious dose.

** produced in serum-free vero cells by recombinant dna technology.

The powder is a white, homogenous, freeze-dried powder with possible retraction at the base, and may form a ring-shaped cake.

The solvent (0.4% sodium chloride solution) is a clear, colorless liquid.

After reconstitution with the solvent provided, dengvaxia is a clear, colorless liquid with the possible presence of white to translucent particles.

Excipients/inactive ingredients: essential amino acids including l-phenylalanine, non-essential amino acids, l-arginine hydrochloride, sucrose, d-trehalose dihydrate, d-sorbitol, trometamol, urea, sodium chloride, water for injections.


Mechanism of action:

Dengvaxia contains dengue virus serotypes 1, 2, 3 and 4 that have been weakened. Dengvaxia works by stimulating the body's natural defenses (immune system), which produces its own protection (antibodies) against the viruses that cause dengue disease.

Dengue is a viral infection transmitted to humans through the bite of an infected aedes mosquito. Dengue is not transmitted directly from person-to-person. Nevertheless the virus which replicates in an infected individual can be transmitted to other humans through mosquito bites for 4-5 days (maximum 12 days) after the first symptoms appear.

Dengue disease results in a wide range of symptoms including fever, headache, pain behind the eyes, muscle and joint pain, nausea, vomiting, swollen glands or skin rash. Symptoms usually last for 2-7 days. Dengue disease can also be asymptomatic.

However, occasionally dengue can be severe and potentially lead to hospitalization and in rare cases to death. Severe dengue is characterized by high fever and any of the following symptoms: severe abdominal pain, persistent vomiting, rapid breathing, severe bleeding, bleeding in stomach, bleeding gums, fatigue, restlessness, coma, seizure and organ failure.


More information about dengvaxia - First vaccine against dengue

Sanofi awaits govt approval to launch dengue vaccine in india


Sanofi pasteur - Dengue vaccine frequently asked questions

Table of Content

About Luprotas 22.5Mg Vial
When is Luprotas 22.5Mg Vial prescribed?
What are the side effects of Luprotas 22.5Mg Vial ?
Key highlights of Luprotas 22.5Mg Vial
What are the dosage instructions?
How does medicine works?